TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Mias Lymfterapi AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7
|
9
|
11 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-2
|
4
|
4 |
| EBITDA |
-2
|
4
|
4 |
| Total assets |
21
|
25
|
22 |
| Current assets |
21
|
25
|
22 |
| Current liabilities |
1
|
2
|
3 |
| Equity capital |
20
|
23
|
19 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.2%
|
92.0%
|
86.4% |
| Turnover per employee |
7
|
9
|
11 |
| Profit as a percentage of turnover |
-28.6%
|
44.4%
|
36.4% |
| Return on assets (ROA) |
-9.5%
|
16.0%
|
18.2% |
| Current ratio |
2100%
|
1250.0%
|
733.3% |
| Return on equity (ROE) |
-10.0%
|
17.4%
|
21.1% |
| Change turnover |
-2
|
-2
|
4 |
| Change turnover % |
-20%
|
-18%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.